Product category:
Microplates/microarrays and readers
News Release from: Scienion
Edited by the Laboratorytalk Editorial
Team on 16 October 2006
Alan Bullock appointed chairman of
Scienion
In December 2002, Scienion, a complex supplier of biochip products, hardware and services, appointed a new, additional chairman in Alan Bullock
CEO Holger Eickhoff declared: "We are pleased that an authority recognised in the industry has decided to join our biotechnology company "Thanks to Alan's experience, contacts and strategic-conceptional abilities, Scienion will be able to expand its market positions achieved for microarrays and continue with its internationally successful operations"
This article was originally published on Laboratorytalk on 9 Sep 2004 at 8.00am (UK)
Related stories
Antibody chips for research and diagnostics
Chips will allow the simultaneous identification of many hundred medically relevant proteins from complex biological substrates
Dispensing of tiny liquid volumes
Instrument allows the aspiration of ultra low level liquid volumes within the picoliter to nanoliter range from different reservoirs and contact-free delivery
Bullock comes from England, where he trained and earned his PhD as a nuclear physicist.
After various stations in companies in the semiconductor industry, he switched into the biotechnology sector of Leica Microsystems.
Close contacts between Alan Bullock and the Scienion team resulted primarily during his tenure as director of the German headquarters of Packard BioScience (USA), one of the world's leading manufacturers of device systems, reagents and services for the life sciences industry.
Bullock has worked with the Berlin biotech company since May 2002 as a management and strategy consultant in the areas of marketing and sales.
"For me Scienion is an exciting challenge, as here the scientific expertise of the team is combined with an technology platform as well as products in demand and reliable service - all of these are excellent sales arguments," the new chairman stated, looking forward to his new job.
Also effective immediately, the two new directors for research and development, Eckhard Nordhoff and Volker Heiser, will take over the Scienion array hardware and chip manufacturing divisions.
While Nordhoff is one of the inventing fathers of the platform technology implemented for the manufacture of 2D/3D microarrays at Scienion and belongs to the pioneers of biological mass spectrometry, the molecular biologist Heiser counts among his achievements as director of the drug screening group at the Max Planck Institute for Molecular Genetics (Dr Lehrach's department) the development of an automated screening platform for massively parallel analyses. Request free introductory details about products from Scienion ...
• Scienion: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
